Equities Analysts Decrease Earnings Estimates for IDEX Co. (NYSE:IEX)
IDEX Co. (NYSE:IEX) – Research analysts at Oppenheimer cut their Q3 2019 earnings per share estimates for shares of IDEX in a research note issued on Sunday, July 28th. Oppenheimer analyst B. Blair now expects…

From the Equity Insider archive. This article dates from Jul 30, 2019 and is preserved as first published.
IDEX Co. (NYSE:IEX) – Research analysts at Oppenheimer cut their Q3 2019 earnings per share estimates for shares of IDEX in a research note issued on Sunday, July 28th. Oppenheimer analyst B. Blair now expects that the industrial products company will post earnings per share of $1.46 for the quarter, down from their prior estimate of $1.47. Oppenheimer currently has a “Hold” rating on the stock. Oppenheimer also issued estimates for IDEX’s Q4 2019 earnings at $1.44 EPS and FY2019 earnings at $5.85 EPS.
IDEX (NYSE:IEX) last posted its quarterly earnings data on Thursday, July 25th. The industrial products company reported $1.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The business had revenue of $642.10 million for the quarter, compared to the consensus estimate of $655.87 million. IDEX had a net margin of 17.11% and a return on equity of 21.20%. The company’s revenue was up 1.2% compared to the same quarter last year. During the same period last year, the firm posted $1.40 earnings per share.
Other equities analysts also recently issued reports about the stock. Zacks Investment Research downgraded shares of First Merchants from a “hold” rating to a “sell” rating in a report on Monday, July 1st. Stifel Nicolaus reissued a “buy” rating and issued a $34.00 price target on shares of Rhythm Pharmaceuticals in a research note on Monday. Wells Fargo & Co reissued a “hold” rating and issued a $130.00 price target on shares of Kimberly Clark in a research note on Tuesday, July 23rd. Berenberg Bank reissued a “buy” rating and issued a GBX 150 ($1.96) price target on shares of Tharisa in a research note on Wednesday, May 15th. Finally, DA Davidson reissued a “neutral” rating on shares of IDEX in a research note on Friday, April 26th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $162.38.
IEX opened at $167.44 on Tuesday. The company has a current ratio of 3.36, a quick ratio of 2.53 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $12.78 billion, a P/E ratio of 29.83, a price-to-earnings-growth ratio of 2.90 and a beta of 1.25. IDEX has a 52-week low of $117.72 and a 52-week high of $173.84. The firm’s fifty day moving average is $167.20.
Zacks Investment Research downgraded shares of First Merchants from a “hold” rating to a “sell” rating in a report on Monday, July 1st.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Tuesday, July 16th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.19%. The ex-dividend date is Monday, July 15th. IDEX’s dividend payout ratio is currently 36.97%.
In related news, SVP Daniel J. Salliotte sold 7,125 shares of the firm’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $153.06, for a total transaction of $1,090,552.50. Following the completion of the sale, the senior vice president now directly owns 44,545 shares in the company, valued at $6,818,057.70. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Michael J. Yates sold 15,178 shares of the firm’s stock in a transaction dated Friday, May 3rd. The stock was sold at an average price of $156.97, for a total transaction of $2,382,490.66. Following the sale, the vice president now owns 38,590 shares of the company’s stock, valued at $6,057,472.30. The disclosure for this sale can be found here. Over the last three months, insiders sold 103,423 shares of company stock worth $16,055,566. Insiders own 1.20% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the stock. FMR LLC increased its position in IDEX by 5.4% during the first quarter. FMR LLC now owns 1,826,878 shares of the industrial products company’s stock worth $277,210,000 after purchasing an additional 93,320 shares during the last quarter. Cleararc Capital Inc. acquired a new stake in shares of IDEX during the first quarter valued at about $295,000. OLD National Bancorp IN acquired a new stake in shares of IDEX during the first quarter valued at about $285,000. Texas Permanent School Fund increased its position in shares of IDEX by 2.5% during the first quarter. Texas Permanent School Fund now owns 51,462 shares of the industrial products company’s stock valued at $7,809,000 after acquiring an additional 1,264 shares during the last quarter. Finally, Dupont Capital Management Corp increased its position in shares of IDEX by 129.0% during the first quarter. Dupont Capital Management Corp now owns 119,424 shares of the industrial products company’s stock valued at $18,121,000 after acquiring an additional 67,263 shares during the last quarter. Hedge funds and other institutional investors own 94.61% of the company’s stock.
IDEX Company Profile
IDEX Corporation, through its subsidiaries, operates as an applied solutions company worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.


